Just over 5 weeks until the end of the financial year and according to previous guidance by the company we should be expecting:
* 2 x NEW phara collaberations - each bigger than the last * Jansen collaberation extension - with much larger $'s * Possible update on collaberations with Roche, Pfizer or Medimmune..?
If any or all of these come through it could really put a rocket under the share price and clear out a lot of doubters. Happy days for all those patient longs.
If they miss guidance again, not with standing they could announce them post 30 June, then the share price could get a hammering.
Interesting times and I'm looking forward to seeing how it plays out.
How do you see it, can Nick deliver?
PYC Price at posting:
4.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)